
NSF Research Shows Americans Demand Greater Clarity and Standardization in Food Labeling
ANN ARBOR, Mich.--(BUSINESS WIRE)-- NSF, a leading global public health and safety organization, today released key findings from a survey focused on understanding the effectiveness of US food labeling and its role in consumer decisions.
'Health and wellness continue to be a focus for most consumers, and with the growing popularity of label-review apps and lack of critical food labeling information in e-commerce, NSF's research demonstrates that many consumers are reading labels with a more critical eye,' said Michelle Anstey, Regulatory Manager at NSF. 'The food industry must respond to these evolving consumer demands, prioritizing more transparent, accessible and reliable labeling practices as regulations are updated and introduced.'
The research, which surveyed 1,000 Americans, highlights several challenges, including a lack of confidence in food labels, desired improvements in labeling and the need for standardized sustainability metrics.
Key Findings:
Labels are a key touchpoint: 83% of US consumers read food labels before making a purchase decision. 64% pay more attention to labels compared to five years ago. When reading food labels, adults first look for the expiration date (86%), ingredients list (79%), health claims (78%), allergen warnings (77%) and country of origin (77%)
At the same time, confidence is lacking: Only 16% of adults find health claims very trustworthy. Just 37% rate food labeling in the US better than labeling in other countries.
Consumers want clearer labels: 1 in 5 struggle to interpret nutritional information on food labels. Respondents want to see more detailed processing information (82%) and comprehensive allergen information (80%) on the food they're purchasing.
Sustainability is top-of-mind: 67% consider sustainability factors important in food purchasing decisions yet only 39% feel current food labels adequately address sustainability. 69 % would like to see ethical sourcing information on product labels.
'NSF's consumer survey results point us in the right direction as we revisit and improve food labeling in 2025,' added Anstey. 'By improving transparency and standardization, we can better communicate with consumers and support a more sustainable, trustworthy food supply chain.'
Easy to interpret, validated food labeling can help consumers make educated decisions related to diet and well-being. According to the American Heart Association, nearly 68% of people recognize healthy eating habits as an important factor in improving a person's chance for a long and healthy life. 1
Recent regulations emphasize the increased criticism of food labels among consumers, including bans of some chemicals of concern, such as Red No. 3, in some states, as well as the proposal for an FDA rule that would require front-of-package nutritional information.
NSF supports food manufacturers and retailers with innovative solutions that meet consumer expectations and regulatory labeling requirements. The organization also validates health claims, such as Organic, non-GMO, Gluten-Free, plant based, Raised Without Antibiotics and more, helping businesses to differentiate their products while increasing sales.
Download the white paper.
NSF
NSF is an independent, global services organization dedicated to improving human and planet health for more than 80 years by developing public health standards and providing world-class testing, inspection, certification, advisory services and digital solutions to the food, nutrition, water, life sciences and consumer goods industries. NSF serves 40,000 clients in 110 countries and is a World Health Organization (WHO) Collaborating Center on Food Safety, Water Quality and Medical Device Safety.
1 Alarming trends call for action to define the future role of food in nation's health, American Heart Association, 2024

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
FDA commissioner: Measles killing about one in 1,000 victims
(NewsNation) — Health officials in the U.S. are telling all travelers that regardless of where you're flying to, it's important to make sure you're vaccinated against measles. The Centers for Disease Control and Prevention updated its guidance last week. The health agency previously advised travelers of the importance of vaccination for travelers going to countries that have had an outbreak of the disease. Lead, arsenic found in popular rice brands: Study FDA Commissioner Dr. Marty Makary told NewsNation that measles has a mortality rate of about one in 1,000 people, and usually found in people with co-morbid conditions. But he added that vaccination is effective, and that those who've had the disease before needn't worry. 'It's basically natural immunity once you've recovered from measles,' Makary said. The travel notice advises two vaccination doses for all Americans ages 1 and older. An early dose is advised for traveling infants ages 6 months to 11 months. The U.S. has seen more than 1,000 measles cases so far this year. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Business Wire
an hour ago
- Business Wire
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
GENT, Belgium & MALVERN, Pa. & TOKYO--(BUSINESS WIRE)--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G immunoassay analyzers. This CLEIA (chemiluminescent enzyme immunoassay) assay is available for Research Use Only (RUO) and allows for the quantitative measurement of soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) in human cerebrospinal fluid (CSF) and blood within just 35 minutes. sTREM2 complements established biomarkers like GFAP, NfL, and pTau by adding essential insight into neuroinflammation - offering a more complete picture of the disease on a single platform. Share sTREM2 is a promising biomarker of microglial activation, offering researchers insights into neuroinflammation linked to Alzheimer's and other neurodegenerative diseases. sTREM2 can be valuable for capturing the dynamics of inflammatory responses or for monitoring inflammatory modulators. This test complements Fujirebio's growing portfolio of neuro biomarkers, including GFAP, NfL, and pTau, and reinforces the company's leading position in advancing neuro biomarker research tools and diagnostics. 'By adding sTREM2 to our neuro portfolio, we're enabling a more comprehensive view of neurological disease mechanisms,' said Goki Ishikawa, President and CEO of Fujirebio Holdings, Inc. 'sTREM2 complements established biomarkers like GFAP, NfL, and pTau by adding essential insight into neuroinflammation - offering a more complete picture of the disease on a single platform.' The new test allows researchers and clinical research professionals to further study and understand the potential clinical utility of this promising microglial biomarker. The availability of the assay on the fully automated random access LUMIPULSE G analyzers gives researchers access to convenient, accurate, and robust measurement of sTREM2. Already widely available for routine use in neurological disease testing worldwide, these analyzers meet all necessary quality, throughput, and regulatory requirements. About Fujirebio Fujirebio, a member of H.U. Group Holdings Inc., is a global leader in the field of high-quality RUO and in vitro diagnostics (IVD) testing. It has more than 50 years' accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Fujirebio was the first company to develop and market CSF biomarkers under the Innogenetics brand over 25 years ago. Fujirebio offers a comprehensive line-up of manual and fully automated assays for neurological diseases and consistently partners with organizations and clinical experts across the world to develop new pathways for earlier, easier and more complete neurodegenerative diagnostic tools. More information can be found at
Yahoo
2 hours ago
- Yahoo
Canadian fire smoke threatens air quality in Canada, US as it reaches Europe
Parts of Canada and the US received alerts for hazardous air quality as hundreds of wildfires spread throughout Canada, forcing 26,000 people to evacuate and spewing smoke across the Atlantic in Canada's latest extreme weather event. Canada's wildfires, which have already forced evacuations of more than 26,000 people, continued their stubborn spread Tuesday, with heavy smoke choking millions of Canadians and Americans and reaching as far away as Europe. Alerts were issued for parts of Canada and the neighboring United States warning of hazardous air quality. A water tanker air base was consumed by flames in Saskatchewan province, oil production has been disrupted in Alberta, and officials warned of worse to come with more communities threatened each day. "We have some challenging days ahead of us," Saskatchewan Premier Scott Moe told a news conference, adding that the number of evacuees could rise quickly. Every summer, Canada grapples with forest fires, but an early start to the wildfire season this year and the scale of the blazes -- over two million hectares (494,000 acres) burned -- is worrying. Read moreClimate change made LA wildfires worse, says study The provinces of Saskatchewan and Manitoba have been hardest hit. Both declared wildfire emergencies in recent days. (FRANCE 24 with AFP) Read more on FRANCE 24 EnglishRead also:South Korea firefighters deploy helicopters as country's largest wildfires reigniteWildfire on remote French island threatens wildlife and research station